02258nas a2200313 4500000000100000008004100001260002300042653001800065653001300083653001400096653002000110653001800130100001300148700002600161700001600187700001500203700001300218700001100231700001300242700001700255700001700272700001500289245012100304856007800425300000600503490000700509520141400516022001401930 2025 d bFrontiers Media SA10aquestionnaire10aValidity10aAwareness10aEarly detection10aSkin diseases1 aAbqari U1 aAtoillah Isfandiari M1 aDharmawan Y1 aBeladina N1 aMatani J1 aIbad M1 aKusuma D1 aDwirahmadi F1 aRichardus JH1 aKorfage IJ00aEarly Detection of Common Skin Diseases, Including Leprosy: Development and Validation of an Awareness Questionnaire uhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12202976/pdf/ijph-70-1607938.pdf a80 v703 a

Objectives Skin diseases account for 1.79% of the global disease burden, though their impact may be underreported due to limited research. Raising awareness about early detection is essential, but tools to measure this are scarce. This study aimed to develop and validate a questionnaire assessing community awareness and early detection of common skin diseases, including leprosy, in Indonesia.

Methods The questionnaire was drafted in English, translated into Bahasa Indonesia, and tested for face validity, content validity, and internal consistency. A pilot test with 25 participants and a field test with 680 participants were conducted. Results were analyzed using Cronbach alpha and descriptive methods.

Results The final questionnaire comprised 17 questions on skin disease: common knowledge, intentions on prevention and health-seeking behavior. Validity and internal consistency were confirmed during pilot testing, and no participants in the field test reported confusion. The Cronbach alpha score exceeded 0.70, confirming strong internal consistency.

Conclusion This validated questionnaire can assess public awareness of early skin disease detection. It is available for international adaptation and may help improve early detection and prevention in Indonesia’s healthcare system.

 a1661-8564